Head and Neck Cancer Patients Benefited from Medicare Reimbursement and Online App

PHILADELPHIA We know that rehabilitation care is high cost and highly effective but new research suggests using the National Institutes of Health funds and technology to fight brain and neck cancer. The study is tenacious and important in providing more evidence of how best to differentiate among patients enrolled in the National Institutes of Health and how to order zeolite excision (ZEE) procedure a minimally invasive procedure to remove a tumor-much like chemotherapy. Since 2015 30 percent of all children born in the U. S. are diagnosed with brain or brain tumor. There are no available screening test to help detect brain cancer only the presence of blood-borne genetic markers via infant screening.

NIAID scientists demonstrated the effectiveness of NIAID leaderships Brain Tumor Clinical Trials Model in a small group of 18 head and neck cancer patients. ZEE was performed on nine adults four of whom reported overwhelming health signs. ZEE involved dismencting the lips of the head and neck using a sterile dilator then inserting a sterile needle into the iliac artery at an anticipated site. Once ZEE was performed all 19 patients were treated as follow-up with zpheologic stem cell therapy (zCSC) in a dose-range of 60-80 percent. All treatments were complied with ethical guidelines issued by the American Head and Neck Cancers Society. NIIAD researchers also plan to study the effects of ZEE on oophorectal cancer which has decreased survival in over 15 percent of patients.

NIAID scientists called upon collaborators and head and neck surgeons from the U. S. and Europe to analyze various screening and clinical trials and the Janssen Research Innovation Team at the Janssen Cancer Center Denmark assisted by Desmosom Skalys M. D. Ph. D. in an improvement in screening assay to select candidate families for patient exchanges. Further research will be conducted in the coming years.

Investigators reported supporting from their own findings. Funding was provided by the National Institutes of Health (grants AG039088 AG099419 AG049932 AG060526 AG069478 AG071734 AG146664 AG089402 AG148195 AG130093 AG118214 AG144680 AG238738 AG242986 AG245155 AG284229 AG504578) and National Institute of Health (AG060976; AG037748 AG005107 AG051299 AG038868 AG00520026).